SCHEMBL4884973

SCHEMBL4884973

COc1ccc(CN2C[C@@H]3C(c4ccc(NC(=O)OCc5ccccc5)cc4)[C@@H]3C2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
MAOB P27338 4/20 0.53
KDM1A O60341 3/20 0.53
MAOA P21397 2/20 0.53
TGM2 P21980 1/20 0.52
RCOR1 Q9UKL0 2/20 0.52
FAAH O00519 1/20 0.51
ALDH1A1 P00352 1/20 0.51
BCHE P06276 3/20 0.48
ACHE P22303 3/20 0.48
MAPT P10636 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TP53 P04637 1/20 0.48
FABP7 O15540 1/20 0.47
FABP5 Q01469 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14197151 1.00 LMNA (0.54) LMNAMAOBKDM1AMAOATGM2
SCHEMBL5375022 0.88 LMNA (0.48) LMNAMAOBTGM2FAAHALDH1A1
SCHEMBL14370643 0.88 LMNA (0.48) LMNAMAOBTGM2FAAHALDH1A1
SCHEMBL14197113 0.87 LMNA (0.48) LMNAMAOBTGM2FAAHALDH1A1
SCHEMBL4879327 0.87 LMNA (0.48) LMNAMAOBTGM2FAAHALDH1A1
SCHEMBL4877680 0.85 FAAH (0.53) LMNAFAAHALDH1A1MAPTL3MBTL1
SCHEMBL31043796 0.82 LMNA (0.47) LMNATGM2FAAHALDH1A1MAPT
SCHEMBL1223807 0.82 RAB9A (0.67) LMNAMAOBKDM1AMAOARCOR1
SCHEMBL11813314 0.80 TP53 (0.68) LMNAALDH1A1MAPTTP53NPC1
SCHEMBL8068944 0.80 SIGMAR1 (0.62) FAAHALDH1A1KMT2ASMN1; SMN2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES PFIZER INC 2008-04-17 US disclosed
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues RENSLO ADAM (US) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues OXA1L, CYP51A1, CYP2C19 LMNA 3131/4885MAOB 1797/4885KDM1A 3017/4885
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES OXA1L, CYP51A1, CYP2C19 LMNA 2947/4885MAOB 1736/4885KDM1A 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.